Pharmadax Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 253.590 million compared to TWD 113.156 million a year ago. Operating loss was TWD 121.903 million compared to TWD 155.754 million a year ago. Net loss was TWD 125.201 million compared to TWD 158.879 million a year ago. Basic loss per share from continuing operations was TWD 1.86 compared to TWD 2.63 a year ago.